← Back to Search

Artificial Intelligence (AI) Activity for High Blood Pressure

N/A
Waitlist Available
Led By Yoshimi Fukuoka, PhD, RN, FAAN
Research Sponsored by University of California, San Francisco
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline (run-in period), 4 week-test period, and 3-month intervention period
Awards & highlights

Study Summary

This study is evaluating whether an artificial intelligence intervention can help improve physical activity for individuals with hypertension.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline (run-in period), 4 week-test period, and 3-month intervention period
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline (run-in period), 4 week-test period, and 3-month intervention period for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Changes in weekly daily average steps
Duration (minutes) of moderate to vigorous intensity physical activity (MVPA) per day
Secondary outcome measures
Changes in Body Mass Index (BMI)
Changes in Systolic blood pressure (SBP)
Changes in diastolic blood pressure (DBP)
+3 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Artificial Intelligence (AI) Activity groupExperimental Treatment1 Intervention
Participants in this group receive an AI based intervention (automated and personalized daily step goal intervention involving a sophisticated activity analytics algorithm using advanced statistics and machine learning and message)
Group II: Control groupActive Control1 Intervention
Participants in this group receive a standardized and fixed 10,000 daily steps goal intervention.

Find a Location

Who is running the clinical trial?

University of California, San FranciscoLead Sponsor
2,505 Previous Clinical Trials
15,237,548 Total Patients Enrolled
Yoshimi Fukuoka, PhD, RN, FAANPrincipal InvestigatorUniversity of California, San Francisco

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~1 spots leftby Apr 2025